DalsnaFinance › IPOs › Lyell Immunopharma › IPO
Lyell Immunopharma, Inc. completed its initial public offering on NASDAQ on June 17, 2021, pricing at $17.00 a share.
| Ticker | LYEL |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | June 17, 2021 |
| Offering price | $17.00 |
| Shares offered | 25,000,000 |
| Total raised | $425M |
Lyell Immunopharma, Inc. sold 25,000,000 shares at $17.00 each on NASDAQ. Multiplied out, that is $425 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $425 million total recorded for the deal.
Lyell Immunopharma, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Lyell Immunopharma, Inc.. This page is general information, not investment advice.